Children with infantile spasms are likely to have a poor outcome. Outcome measures for
infantile spasms include primary response to treatment, relapse of spasms, neurological …

Objective: To determine the current best practice for treatment of infantile spasms in children.
Methods: Database searches of MEDLINE from 1966 and EMBASE from 1980 and searches …

В руководстве представлены результаты 60-летней работы автора в области детской
и взрослой неврологии и эпилептологии. Впервые эпилептология представлена в …

Vigabatrin (VGB) is a structural analogue of γ‐aminobutyric acid (GABA) that irreversibly
inhibits GABA‐transaminase (GABA‐T), increasing brain levels of GABA. VGB is under …

Objective Population‐based studies on infantile epilepsy syndromes are scarce. Our aim
was to provide syndrome‐specific data on the incidence and outcome of epilepsy in a …

Infantile spasms constitute both a distinctive seizure type and an age-specific epilepsy
syndrome that have been extensively described for over a century. Standardization of the …

Purpose: Investigate whether patients on vigabatrin demonstrated new‐onset and reversible
T2‐weighted magnetic resonance imaging (MRI) abnormalities. Methods: MRI of patients …

The Fifth Eilat Conference on New Antiepileptic Drugs (AEDs) took place at the Dan Hotel,
Eilat, Israel, 25–29 June 2000. Basic scientists, clinical pharmacologists and neurologists …

To investigate the impact of treatment lag in infantile spasms (IS) on treatment response,
occurrence of later epilepsy, and long-term cognition and behavior in patients with one …

The following aspects are reviewed: Does the aetiology influence the outcome of infantile
spasms? Does the treatment influence the outcome? Can the outcome be predicted? Can …